NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: A high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker

MLA

Pathologie Moleculair, et al. NOTCH1 Fusions in Pediatric T-Cell Lymphoblastic Lymphoma: A High-Risk Subgroup with CCL17 (TARC) Levels as Diagnostic Biomarker. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1450186536&authtype=sso&custid=ns315887.

APA

Pathologie Moleculair, Pathologie Pathologen staf, PMC Medisch specialisten, Genetica, Cancer, Kroeze, E., Kleisman, M. M., Kester, L. A., Scheijde-Vermeulen, M. A., Sonneveld, E., Buijs-Gladdines, J. G. C., Hagleitner, M. M., Meyer-Wentrup, F. A. G., Veening, M. A., Beishuizen, A., Meijerink, J. P. P., Loeffen, J. L. C., & Kuiper, R. P. (2024). NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: A high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker.

Chicago

Pathologie Moleculair, Pathologie Pathologen staf, PMC Medisch specialisten, Genetica, Cancer, Emma Kroeze, Michelle M. Kleisman, et al. 2024. “NOTCH1 Fusions in Pediatric T-Cell Lymphoblastic Lymphoma: A High-Risk Subgroup with CCL17 (TARC) Levels as Diagnostic Biomarker.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1450186536&authtype=sso&custid=ns315887.